A double-blind, placebo-controlled, randomized, phase 2 study to evaluate the efficacy and safety of switch maintenance therapy with the anti-TA-MUC1 antibody PankoMab-GEX … J Ledermann, J Sehouli, B Zurawski, F Raspagliesi, U De Giorgi, ... Annals of Oncology 28, v626, 2017 | 18 | 2017 |
Efficacy and safety of CetuGEX in recurrent/metastatic squamous cell carcinoma of the head and neck (RM-HNSCC): Results from the randomized phase II RESGEX study. U Keilholz, A Kawecki, A Dietz, B Zurawski, M Schenker, ... Journal of Clinical Oncology 36 (5_suppl), 59-59, 2018 | 8 | 2018 |
Epidoxorubicin and paclitaxel combination in neoadjuvant setting for stage IIB-IIIA breast cancer: preliminary results N Ghilezan, C Vitoc, R Tanasscu, D Grecea, S Mihutiu, A Mihailov Proc Am Soc Clin Oncol 18, 94a, 1999 | 5 | 1999 |
Self-efficacy in breast cancer patients C Lupau, S Mihutiu PSYCHO-ONCOLOGY 27, 165-165, 2018 | | 2018 |
Posttraumatic growth after breast cancer C Lupau, S Mihutiu PSYCHO-ONCOLOGY 26, 141-141, 2017 | | 2017 |
Psychological effects of radical mastectomy in women breast cancer: is" unconditional self-acceptance" the key to minimize the impact? C Lupau, S Mihutiu PSYCHO-ONCOLOGY 25 (SP. S 3), 76-76, 2016 | | 2016 |
Her2+ metastatic gastric cancer, treated with biological Therapy-Trastuzumab/Herceptin-case report O Fratila, S Mihutiu, T Ilias JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY 28, 668-668, 2013 | | 2013 |
P-0273 Hepatic Metastasis and Reccurence of Colorectal Cancer Assesment by 18FDG PET/CT O Fratila, S Mihutiu, O Straciuc, T Ilias Annals of Oncology 23, iv23, 2012 | | 2012 |
HEPATIC METASTASIS AND RECCURENCE OF COLORECTAL CANCER ASSESMENT BY 18FDG PET/CT O Fratila, S Mihutiu, O Straciuc, T Ilias ANNALS OF ONCOLOGY 23, 109-109, 2012 | | 2012 |